American Heart Journal
Volume 158, Issue 5 , Pages 713-718, November 2009

Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST)

  • Willem Dewilde, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Willem Dewilde, MD, Sint Antonius Hospital, Nieuwegein, The Netherlands, Koekoekslaan 1, 3435 CM Nieuwegein.
    • ,
  • Jurriën Ten Berg, MD, PhD, FACC

Sint Antonius Hospital, Nieuwegein, The Netherlands

Received 14 February 2009; accepted 11 September 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 RCT no. NCT00769938.

PII: S0002-8703(09)00718-2

doi:10.1016/j.ahj.2009.09.001

American Heart Journal
Volume 158, Issue 5 , Pages 713-718, November 2009

Article Tools

* Image Usage & Resolution